Jotaro Mikami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jotaro Mikami has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Chikara Ohyama
Department of Advanced Transplant and Regenerative Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
2 shared publications - Hayato Yamamoto
Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
2 shared publications - Naoki Fujita
Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
2 shared publications - Shingo Hatakeyama
Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
2 shared publications - Takuma Narita
Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
2 shared publications - Teppei Okamoto
Department of Urology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Springer Nature in BMC Cancer
Real-world patterns of first-line treatment selection after the introduction of enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
- 25 August 2026
- Published by Springer Nature in BMC Cancer
Open AccessReal-world patterns of first-line treatment selection after the introduction of enfortumab vedotin plus pembrolizumab for advanced urothelial carcinoma
- Open Access
- 27 March 2026
- Published by Springer Nature in Cancer Imaging
- Vol. 26 (1)
CT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study
To evaluate whether treatment-induced changes in tumor-bearing renal artery caliber on contrast-enhanced CT are associated with pathological response and p
- 27 March 2026
- Published by Springer Nature in Cancer Imaging
- Vol. 26 (1)
Open AccessCT-based renal artery caliber change as a potential imaging marker of treatment response in renal cell carcinoma; an exploratory imaging study
To evaluate whether treatment-induced changes in tumor-bearing renal artery caliber on contrast-enhanced CT are associated with pathological response and p